Evidence map›Paper›PMID 42177502›Full record

ArticleMicrobial cell factories2026

Expanding the substrate spectrum in engineered Pseudomonas taiwanensis for efficient production of 4-coumarate from lignocellulosic sugars.

Benedikt Wynands, Sophia Feltes, Nadine Teófilo da Silva, Tino Polen, Nick Wierckx

Abstract read
In one paragraph

Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Benedikt WynandsInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.ORCID http://orcid.org/0000-0001-8599-3205
Sophia FeltesInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
Nadine Teófilo da SilvaInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
Tino PolenInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.ORCID http://orcid.org/0000-0002-0065-3007
Nick WierckxInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany. n.wierckx@fz-juelich.de.ORCID http://orcid.org/0000-0002-1590-1210

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aromatics are important building blocks for polymers, pharmaceuticals, and advanced materials, but their current production relies on petrochemical processes. Biotechnological de novo production from renewable bio-based feedstocks with microbial cell factories provides a sustainable alternative. In this study, we enhanced 4-coumarate production in Pseudomonas taiwanensis from glucose and glycerol compared to previously published producers. This was achieved through heterologous expression of tyrosine ammonia-lyase (TAL) from Rivularia sp. PCC7116, which debottlenecked the specific deamination of tyrosine. Moreover, deletion of the phosphoenolpyruvate carboxylase-encoding gene ppc further increased the production. Subsequently, the substrate spectrum for efficient aromatics production was expanded to include the abundant pentoses, xylose and arabinose. Heterologous non-oxidative assimilation pathways were integrated into P. taiwanensis GRC3 chassis strains and growth on xylose and arabinose was improved through adaptive laboratory evolution, whole-genome sequencing, and reverse engineering. Optimized catabolic modules were then transferred to producer strains to enhance or enable 4-coumarate production from xylose and arabinose. Notably, the product yield on xylose increased approximately 3.5-fold with the non-oxidative xylose isomerase pathway compared to the oxidative native Weimberg pathway, without compromising yields on glucose. For the final strain, P. taiwanensis GRC3Δ6-TYR2Δppc-REXA-attTn7::P

Indexed as

Coumaric AcidsLigninMetabolic EngineeringPseudomonasAmmonia-LyasesArabinoseGlucosePropionatesXyloseAmmonia-LyasesArabinoseCoumaric AcidsGlucoseLigninlignocelluloseL-tyrosine ammonia-lyasep-coumaric acidPropionatesXylose4-CoumarateArabinoseAromaticsBiocatalysisMetabolic engineeringPseudomonasTyrosine ammonia-lyaseXylose

Identifiers

PMID42177502
PMCPMC13200318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.